WO2016163799A3 - 2-메톡시-4-(3-(4-메톡시페닐)프로프-1-엔-1-일)페놀을 유효성분으로 하는 암의 치료용 약제학적 조성물 - Google Patents
2-메톡시-4-(3-(4-메톡시페닐)프로프-1-엔-1-일)페놀을 유효성분으로 하는 암의 치료용 약제학적 조성물 Download PDFInfo
- Publication number
- WO2016163799A3 WO2016163799A3 PCT/KR2016/003696 KR2016003696W WO2016163799A3 WO 2016163799 A3 WO2016163799 A3 WO 2016163799A3 KR 2016003696 W KR2016003696 W KR 2016003696W WO 2016163799 A3 WO2016163799 A3 WO 2016163799A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- present
- compound
- methoxyphenyl
- methoxy
- phenol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
본 발명은 신규 화합물 2-메톡시-4-(3-(4-메톡시페닐)프로필-1-엔-1-일)페놀의 항암 용도에 관한 것이다. 본 발명의 화합물은 인 비트로 및 이종이식 동물모델에서 암세포와 종양의 성장을 효과적으로 억제한다. 본 발명의 화합물은 암세포에서 전사인자 STAT3의 DNA 결합 활성을 억제하고, 암세포의 세포사멸(apoptosis)를 유도하며, 세포주기 조절 단백질의 발현을 감소시킴으로써 항암 활성을 나타낸다. 본 발명의 화합물은 강력한 항암제의 활성성분으로 개발될 수 있다.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/564,027 US10166203B2 (en) | 2015-04-10 | 2016-04-08 | Pharmaceutical composition for treating cancer including 2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol as active ingredient |
CN201680021186.6A CN107530300A (zh) | 2015-04-10 | 2016-04-08 | 将2‑甲氧基‑4‑(3‑(4‑甲氧基苯基)丙‑1‑烯‑1‑基)苯酚作为有效成分的癌的治疗用药剂学组合物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2015-0050578 | 2015-04-10 | ||
KR1020150050578A KR101671020B1 (ko) | 2015-04-10 | 2015-04-10 | 2-메톡시-4-(3-(4-메톡시페닐)프로프-1-엔-1-일)페놀을 유효성분으로 하는 암의 치료용 약제학적 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2016163799A2 WO2016163799A2 (ko) | 2016-10-13 |
WO2016163799A3 true WO2016163799A3 (ko) | 2016-12-01 |
Family
ID=57071944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2016/003696 WO2016163799A2 (ko) | 2015-04-10 | 2016-04-08 | 2-메톡시-4-(3-(4-메톡시페닐)프로프-1-엔-1-일)페놀을 유효성분으로 하는 암의 치료용 약제학적 조성물 |
Country Status (4)
Country | Link |
---|---|
US (1) | US10166203B2 (ko) |
KR (1) | KR101671020B1 (ko) |
CN (1) | CN107530300A (ko) |
WO (1) | WO2016163799A2 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101687751B1 (ko) * | 2015-04-09 | 2016-12-19 | 주식회사 중헌제약 | 2-메톡시-4-(3-(4-메톡시페닐)프로필-1-엔-1-일)페놀을 유효성분으로 함유하는 염증성 질환 또는 관절염 치료 또는 예방용 약학적 조성물 |
US11493519B2 (en) | 2019-02-08 | 2022-11-08 | Dewpoint Therapeutics, Inc. | Methods of characterizing condensate-associated characteristics of compounds and uses thereof |
CA3140651A1 (en) * | 2019-05-15 | 2020-11-19 | Whitehead Institute For Biomedical Research | Methods of characterizing and utilizing agent-condensate interactions |
CN110563563B (zh) * | 2019-08-30 | 2021-06-25 | 四川大学 | 一种查耳酮类化合物及其制备方法和用途 |
JP2022548695A (ja) | 2019-09-18 | 2022-11-21 | デューポイント セラピューティクス, インコーポレイテッド | 凝縮体関連特異性のスクリーニング方法及びその使用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050260290A1 (en) * | 2004-05-20 | 2005-11-24 | Rutgers, The State University Of New Jersey | Botanical anti-inflammatory compositions and methods |
US7598294B2 (en) * | 2001-10-03 | 2009-10-06 | Spear Therapeutics Limited | 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
KR20110087930A (ko) * | 2010-01-27 | 2011-08-03 | 영남대학교 산학협력단 | 잔토휴몰 또는 이의 유도체를 함유하는 방사선 항암치료 감수성 증진용 조성물 |
-
2015
- 2015-04-10 KR KR1020150050578A patent/KR101671020B1/ko active IP Right Grant
-
2016
- 2016-04-08 CN CN201680021186.6A patent/CN107530300A/zh active Pending
- 2016-04-08 WO PCT/KR2016/003696 patent/WO2016163799A2/ko active Application Filing
- 2016-04-08 US US15/564,027 patent/US10166203B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7598294B2 (en) * | 2001-10-03 | 2009-10-06 | Spear Therapeutics Limited | 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
US20050260290A1 (en) * | 2004-05-20 | 2005-11-24 | Rutgers, The State University Of New Jersey | Botanical anti-inflammatory compositions and methods |
KR20110087930A (ko) * | 2010-01-27 | 2011-08-03 | 영남대학교 산학협력단 | 잔토휴몰 또는 이의 유도체를 함유하는 방사선 항암치료 감수성 증진용 조성물 |
Non-Patent Citations (2)
Title |
---|
HIYOSHI, H. ET AL.: "2-(4-Hydroxy-3-methoxyphenyl)-benzothiazole suppresses Tumor Progression and Metastatic Potential of Breast Cancer Cells by Inducing Ubiquit in Ligase CHIP", SCIENTIFIC REPORTS, vol. 4, no. 7095, 2014, pages 1 - 10, XP055332089 * |
PATHAK, V. ET AL.: "Syntheses of 2-methoxyestradiol and Eugenol Template based Diarylpropenes as Non-steroidal Anticancer Agents", RSC ADVANCES, vol. 4, no. 66, 2014, pages 35171 - 35185, XP055332088 * |
Also Published As
Publication number | Publication date |
---|---|
WO2016163799A2 (ko) | 2016-10-13 |
US20180133168A1 (en) | 2018-05-17 |
US10166203B2 (en) | 2019-01-01 |
KR101671020B1 (ko) | 2016-11-02 |
CN107530300A (zh) | 2018-01-02 |
KR20160121685A (ko) | 2016-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2016163799A3 (ko) | 2-메톡시-4-(3-(4-메톡시페닐)프로프-1-엔-1-일)페놀을 유효성분으로 하는 암의 치료용 약제학적 조성물 | |
MX2016001587A (es) | Inhibidores de kdm1a para el tratamiento de enfermedades. | |
PH12018500960A1 (en) | Processes for preparing isoquinolinones and solid forms of isoquinolinones | |
PH12020552135A1 (en) | Kdm1a inhibitors for the treatment of disease | |
MX2022008867A (es) | Compuestos de benzaldehido sustituidos y metodos para su uso en incrementar la oxigenacion del tejido. | |
UA107474C2 (uk) | Похідні хроменону з антипухлинною активністю | |
NZ703124A (en) | Process for the preparation of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide | |
MX365939B (es) | Moduladores del transporte nuclear y usos de los mismos. | |
CL2014002757A1 (es) | Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, composicion farmaceutica; y uso en el tratamiento del cancer. | |
MX364992B (es) | Moduladores del transporte nuclear y usos de los mismos. | |
WO2011056021A3 (ko) | 벤조헤테로사이클 유도체의 암 예방 및 치료 또는 암 전이 억제를 위한 용도 | |
MX2015003352A (es) | Extracto de saliva entera de sanguijuela. | |
RU2018135973A (ru) | Фармацевтическая комбинация, содержащая метроформин и дигидрокверценин, и ее применение для лечения рака | |
BR112014011981B8 (pt) | Formulações farmacêuticas sólidas orais, seus processos de preparação e usos | |
EP3207928A4 (en) | Composite preparation, containing novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative and another active ingredient, for preventing or treating metabolic diseases | |
EP3020405A4 (en) | Composition for preventing and treating liver fibrosis or liver cirrhosis,containing, as active ingredient, mesenchymal stem cells derived from human embryonic stem cells | |
BR112014003423A2 (ko) | Trans-splicing ribozyme and the recombinant adenoviruses and their uses, including the treatment of cancer gene | |
MX2020011500A (es) | Moléculas pequeñas para inhibir la actividad de quimiocinas, la actividad de una cinasa y/o el crecimiento de células cancerosas. | |
WO2017091885A8 (en) | Monocarboxylate transporter 4 (mct4) antisense oligonucleotide (aso) inhibitors for use as therapeutics in the treatment of cancer | |
WO2014165723A3 (en) | Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells | |
MX2012013478A (es) | Composicion para evitar perdida del cabello o estimular crecimiento del cabello. | |
WO2012108748A3 (ko) | 합환피 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물 | |
JOP20180071A1 (ar) | استخدام مشتقات أمينو ألكيل بنزوثيازبين | |
WO2012108747A3 (ko) | 토목향 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물 | |
BR112018011196A2 (pt) | uso de pirimido-pirimidazinonas para tratar o câncer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16776902 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15564027 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16776902 Country of ref document: EP Kind code of ref document: A2 |